Gilead Sciences, Inc.

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Overview
Date Founded

1987

Headquarters

333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404

Type of Company

Public

Employees (Worldwide)

13.6K

Industries

Biotechnology
Hospitals & Patient Services
Industrial Machinery & Manufacturing

Company Description

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Contact Data
Trying to get in touch with decision makers at Gilead Sciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Chief Financial Officer & Senior Vice President

Chief Financial Officer

Executive Vice President & Chief Financial Officer

Executive Vice President, Corporate Affairs & General Counsel

Chief Commercial Officer

Chief Medical Officer

Senior Vice President, Corporate Controller & Chief Accounting Officer

Chief Executive Officer, Kite

Executive Vice President-Pharmaceutical Development & Manufacturing

Board of Directors

Chairman & Chief Executive Officer at Gilead Sciences, Inc.

Co-Chief Executive Officer & Trustee at Dignity Health

Co-Founder at Somatus, Inc.

Senior Operating Partner, Portfolio Operations at The Blackstone Group, Inc.

Co-Founder at EQRx, Inc.

Chief Financial Officer at City Year Chicago

Co-Founder at Celsius Therapeutics, Inc.

Former President-Human Health Europe at Merck & Co., Inc.

John G. Kirkwood & Arthur A. Noyes Professor of Chemistry at California Institute of Technology

Chief Executive Officer & Director at DaVita, Inc.

Paths to Gilead Sciences, Inc.
Potential Connections via
Relationship Science
You
Gilead Sciences, Inc.
Owners & Shareholders
Details Hidden

CWGI is the investment adviser to the American Funds Group, a family of 30 funds marketed to individuals exclusively through financial advisers and other intermediaries. American Funds are also used as investment vehicles for 401ks, other retirement plans, variable annuities and 529 college savings plans. The funds have the following characteristics: (1) a long-term, value-oriented approach; (2) long-established, global research; (3) a multiple portfolio counselor system that combines teamwork with individual accountability; (4) experienced, long-tenured investment professionals; and (5) a commitment to low operating expenses, among the lowest in the fund industry. CWGI uses a Multiple Portfolio Counselor System wherein the assets of each fund are divided into smaller, more manageable portions. Research analysts typically manage a segment as well, bringing their expertise directly to bear on the fund's results and portfolio counselors are free to make their own decisions. Investment decisions are based on internal research.

Details Hidden

CRMC's International Investors division invests primarily in the stocks of large-cap growth-oriented companies across practically all sectors. Although they invest internationally, most of their investments are in the stocks of North American companies. They maintain an investment philosophy that is distinguished by four key beliefs: (1) solid research is fundamental to sound investment decisions; (2) investment decisions should not be made lightly; (3) a long-term approach; (4) the capital system.

Details Hidden

Dodge & Cox employs in-house, fundamental bottom-up research, a rigorous valuation discipline, and maintains a long-term investment horizon. Their investment decisions are made by a team of seasoned investment professionals. The firm’s approach stresses an evaluation of risk relative to opportunity and they seek investments that they believe are undervalued by the market.

Recent Transactions
Details Hidden

Gilead Sciences, Inc. purchases MYR GmbH

Details Hidden

Gilead Sciences, Inc. purchases Immunomedics Inc.

Details Hidden

Gilead Sciences, Inc. purchases Jounce Therapeutics, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onGilead Sciences, Inc. purchases Myogen, Inc.

Accountant

Advised onGilead Sciences, Inc. purchases NeXstar Pharmaceuticals, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Kite Pharma, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Myogen, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases Kite Pharma, Inc.

Legal Advisor

Advised onGilead Sciences, Inc. purchases CV Therapeutics, Inc.

Advisors & Consultants
Legal Advisor

Partner, Palo Alto at Cooley LLP

Legal Advisor

Partner, Palo Alto at Cooley LLP

Legal Advisor

Partner, San Francisco at Cooley LLP

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Salix segment consists of sales in the U.S. of GI products. The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Founder at Intellia Therapeutics, Inc.

Key Stats and Financials As of 2020
Market Capitalization
$84B
Total Enterprise Value
$97.5B
Earnings Per Share
$0.1
Enterprise Value / Sales
3.95x
TEVNet Income
792.34x
Debt TEV
0.33x
Revenue
$24.6B
Total Debt
$32.1B
EBITDAMargin
48.39%
Enterprise Value EBITDAOperating
8.11x
EBITDA
$11.9B
Three Year Compounded Annual Growth Rate Of Revenue
-1.94%
Total Equity
$18.2B
Net Profit
$123M
Non-Profit Donations & Grants
Political Donations
$3,300
2006
$2,000
2006
$2,000
2006
Investments
Details Hidden

Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT.

Details Hidden

Vaccitech Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom.

Details Hidden

Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, José Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA.

Investors
Details Hidden

Co-Founder & Senior Managing Director at VV Manager LLC

Details Hidden

Managing Partner, Life Sciences Team at Frazier Healthcare Partners

Suppliers
Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust. It engages in the ownership, operation, development, and redevelopment of life science and technology properties. The firm also provides a space for lease to the life science and technology industries, which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Johnson & Johnson Biotechnology | New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

GlobeImmune, Inc. Medical Support Services | Louisville, Colorado

GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.

Awards & Honors
Rank #86
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #86
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gilead Sciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gilead Sciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Gilead Sciences, Inc..